Healthy volunteers help unlock HIV Drug's secrets
NCT ID NCT07066722
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This completed Phase 1 study looked at how the experimental HIV drug VH4524184 is absorbed by the body and how it interacts with food and other common medicines. It involved 126 healthy adults aged 18 to 60. The goal was to gather important information for future use, not to treat HIV directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Lenexa, Kansas, 66219, United States
-
GSK Investigational Site
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.